human | Q5 |
P496 | ORCID iD | 0000-0002-0271-0562 |
P1153 | Scopus author ID | 41862077700 |
P69 | educated at | Tufts Graduate School of Biomedical Sciences | Q7396838 |
Columbia College | Q4569677 | ||
P108 | employer | NYU Langone Medical Center | Q6956114 |
The Rockefeller University | Q270272 | ||
P106 | occupation | researcher | Q1650915 |
Q34573130 | Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. |
Q55619928 | Correction: Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity. |
Q36636170 | Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis |
Q41937439 | Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis |
Q100533156 | Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes |
Q91080097 | Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus |
Q36580331 | Specialized role of migratory dendritic cells in peripheral tolerance induction |
Q35113616 | Splicing of designer exons informs a biophysical model for exon definition |
Q27312070 | Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity |
Q36306086 | The ever-emerging complexity of α-toxin's interaction with host cells |
Q28509633 | Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein |
Search more.